Update on the Phase 2 Part of Kysa-6, an Open-Label, Single-Arm, Multicenter Study of Kyv-101, a Fully Human CD19 Chimeric Antigen Receptor T-cell Therapy in Generalized Myasthenia Gravis

Transplantation and Cellular Therapy 2026

View at publisher
Authors: Dimitrios Mougiakakos, Sarah Hoffmann, Srikanth Muppidi, Jeremias Motte, Ralf Gold, Michael C Hunter, Charlotte Schubert, Stefanie Schreiber, Christian Geis, Bradley D. Hunter, Everett H. Meyer, Marie Luise Hütter‐Krönke
+8 more Christian R Schultze-Florey, Roland Schroers, Francis Ayuketang Ayuk, Jonathan Wickel, Justin Chou, Baodong Xing, Naji Gehchan, Aiden Haghikia
DOI: 10.1016/j.jtct.2025.12.274
Cited by: 0

Fields of Study & Subjects

Myasthenia Gravis and Thymoma CAR-T cell therapy research T-cell and B-cell Immunology

Publication details

Journal / source
Transplantation and Cellular Therapy
Volume
32
Issue
2
Pages
S199–S199
Publication date
1 February 2026
Language
EN